Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 39851-39900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06591897
Exploration of Gender Differences in Liver Aging
N/ARecruiting
18 participants
Started: Sep 27, 2024 · Completed: Sep 20, 2027
1 condition1 sponsor1 location
NCT06640972
Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists
PHASE2Active, not recruiting
68 participants
Started: Sep 27, 2024 · Completed: Apr 30, 2025
3 conditions1 sponsor1 location
NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
PHASE3Recruiting
4,220 participants
Started: Sep 27, 2024 · Completed: Oct 31, 2032
1 condition1 sponsor450 locations
NCT06068465
A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
PHASE3Recruiting
248 participants
Started: Sep 27, 2024 · Completed: Jan 1, 2026
1 condition1 sponsor27 locations
NCT06676501
A Study to Evaluate the Safety and Efficacy of Staged Bilateral Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for the Treatment of Essential Tremor
NAEnrolling by invitation
20 participants
Started: Sep 26, 2024 · Completed: Nov 1, 2026
2 conditions1 sponsor1 location
NCT07142798
to Assess the Eradication Rate of 14-day Bismuth/Amoxicillin/PCAB Triple Therapy for the Treatment of Helicobacter Pylori Infection
NAEnrolling by invitation
200 participants
Started: Sep 26, 2024 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT06320431
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
PHASE3Recruiting
4,000 participants
Started: Sep 26, 2024 · Completed: Dec 31, 2030
3 conditions2 sponsors24 locations
NCT06935526
Mobile Education and Telephone Monitoring for ICD Patients: Effects on Anxiety, Acceptance, and Self-Efficacy
NAEnrolling by invitation
88 participants
Started: Sep 26, 2024 · Completed: Jun 30, 2025
5 conditions2 sponsors1 location
NCT06616103
Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHB
N/ANot yet recruiting
111 participants
Started: Sep 26, 2024 · Completed: Aug 31, 2025
3 conditions1 sponsor1 location
NCT06799910
Optimization of Fluid Balance Guided by Bioelectrical Impedance Analysis in Patients Undergoing Continuous Renal Replacement Therapy in Critical Care
NARecruiting
60 participants
Started: Sep 26, 2024 · Completed: Jun 30, 2026
7 conditions1 sponsor1 location
NCT06623266
Neck Observation or Elective Neck Dissection in CT1N0M0 OSCC
NARecruiting
300 participants
Started: Sep 26, 2024 · Completed: Sep 30, 2028
2 conditions1 sponsor1 location
NCT06691347
Effectiveness of Trauma Treatment in the Specialist Health Care Services
NARecruiting
270 participants
Started: Sep 26, 2024 · Completed: Dec 31, 2030
6 conditions2 sponsors1 location
NCT06276335
Influence of Timing of Implant Placement on Early Healing Molecular Events
NARecruiting
24 participants
Started: Sep 26, 2024 · Completed: Dec 31, 2026
4 conditions2 sponsors1 location
NCT06357923
Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance in Age
NARecruiting
100 participants
Started: Sep 26, 2024 · Completed: Sep 26, 2026
1 condition1 sponsor1 location
NCT06616259
First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study
PHASE3Not yet recruiting
452 participants
Started: Sep 26, 2024 · Completed: Sep 30, 2029
3 conditions1 sponsor1 location
NCT06026852
Validation of Betalactam ML Prediction Models - TDMAide
NANot yet recruiting
600 participants
Started: Sep 26, 2024 · Completed: May 31, 2025
1 condition3 sponsors1 location
NCT06658236
Upper Extremity Proprioceptive Neuromuscular Facilitation and Chest Expansion Exercises in Cerebral Palsy
NARecruiting
16 participants
Started: Sep 26, 2024 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT06673732
Effects of Muscle Energy Technique With and Without Stationary Cycling on Toe Walking With ASD
NARecruiting
26 participants
Started: Sep 26, 2024 · Completed: Jan 7, 2025
1 condition1 sponsor1 location
NCT05947071
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
PHASE2Recruiting
312 participants
Started: Sep 26, 2024 · Completed: Sep 1, 2027
3 conditions1 sponsor8 locations
NCT06970639
A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases
PHASE3Recruiting
380 participants
Started: Sep 26, 2024 · Completed: Sep 30, 2029
1 condition1 sponsor1 location
NCT07134244
Development of Computational Models to Predict the Short-, Medium- and Long-term Cartilage Degeneration and Pain for Patients With Early-stage Osteoarthritis or Anterior Cruciate Ligament Injury
N/ARecruiting
105 participants
Started: Sep 26, 2024 · Completed: Sep 26, 2036
2 conditions4 sponsors2 locations
NCT06388785
A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia
N/ARecruiting
2,000 participants
Started: Sep 26, 2024 · Completed: May 8, 2027
1 condition1 sponsor2 locations
NCT06621459
Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)
N/ARecruiting
30 participants
Started: Sep 26, 2024 · Completed: Oct 31, 2025
5 conditions1 sponsor1 location
NCT06611969
Inspiratory Muscle Training in Amateur Athletes
NAActive, not recruiting
38 participants
Started: Sep 26, 2024 · Completed: Jul 30, 2025
1 condition1 sponsor1 location
NCT06730841
Dose-Optimized and Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression
NARecruiting
75 participants
Started: Sep 26, 2024 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT06564636
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
N/AEnrolling by invitation
198 participants
Started: Sep 26, 2024 · Completed: Feb 28, 2030
7 conditions1 sponsor12 locations
NCT06568003
TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (TRINITY-US)
NAActive, not recruiting
15 participants
Started: Sep 26, 2024 · Completed: Oct 31, 2030
1 condition2 sponsors3 locations
NCT06661369
Study Comparing the Effects of SPM Techniques, Individually vs. Grouped in Children With ASD
NARecruiting
36 participants
Started: Sep 26, 2024 · Completed: Jan 20, 2025
1 condition1 sponsor1 location
NCT06473532
TEXT4HF: A Randomized Controlled Trial of a Tailored Text Messaging Intervention to Improve Self-Care in Older Adult Patients With Heart Failure
NARecruiting
30 participants
Started: Sep 26, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06776991
Reward Processing and Exposure Therapy for Social Anxiety Disorder
NARecruiting
94 participants
Started: Sep 26, 2024 · Completed: Apr 30, 2029
5 conditions2 sponsors2 locations
NCT04599010
Role of Body Composition in Large for Gestational Age Infants (LGA) With Oral Feeding Difficulty
NARecruiting
40 participants
Started: Sep 26, 2024 · Completed: Feb 28, 2027
3 conditions2 sponsors2 locations
NCT06755515
A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
PHASE2/PHASE3Enrolling by invitation
510 participants
Started: Sep 26, 2024 · Completed: Sep 30, 2028
1 condition1 sponsor1 location
NCT06352632
ACT-GLOBAL Adaptive Platform Trial for Stroke
PHASE3Recruiting
20,000 participants
Started: Sep 26, 2024 · Completed: Sep 30, 2034
1 condition3 sponsors2 locations
NCT06635447
Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients
PHASE3Recruiting
560 participants
Started: Sep 26, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor82 locations
NCT06646471
PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies
PHASE4Recruiting
500 participants
Started: Sep 26, 2024 · Completed: Aug 31, 2028
2 conditions1 sponsor41 locations
NCT06780150
A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
N/ARecruiting
349 participants
Started: Sep 26, 2024 · Completed: Nov 30, 2026
1 condition1 sponsor61 locations
NCT06396416
Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
PHASE4Recruiting
60 participants
Started: Sep 26, 2024 · Completed: Dec 31, 2025
2 conditions4 sponsors1 location
NCT06539507
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725
PHASE1Recruiting
66 participants
Started: Sep 26, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor3 locations
NCT06976788
Creation of a Database of Healthy Subjects With 18FDG PET Brain Imaging as Part of the MOBILE Project (Multimodal Whole-Brain Imaging in Epilepsy)
NARecruiting
30 participants
Started: Sep 26, 2024 · Completed: Sep 25, 2026
3 conditions1 sponsor1 location
NCT06584357
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
N/ARecruiting
1,200 participants
Started: Sep 26, 2024 · Completed: Jul 31, 2028
6 conditions1 sponsor23 locations
NCT06804057
CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry
N/ARecruiting
1,000 participants
Started: Sep 26, 2024 · Completed: Dec 31, 2099
1 condition1 sponsor1 location
NCT06992973
Efficacy of the Association of Fractionated SRS and Subsequent Surgery in Patients With Brain Metastases
NARecruiting
98 participants
Started: Sep 26, 2024 · Completed: Sep 26, 2029
1 condition1 sponsor1 location
NCT06700616
A Study in Patients With Myasthenia Gravis in China
N/AActive, not recruiting
1,200 participants
Started: Sep 26, 2024 · Completed: Dec 30, 2027
1 condition1 sponsor20 locations
NCT06586866
JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases
PHASE2Not yet recruiting
25 participants
Started: Sep 26, 2024 · Completed: Oct 26, 2026
2 conditions1 sponsor0 locations
NCT06564519
Resident Posture Biofeedback Study
NARecruiting
12 participants
Started: Sep 26, 2024 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
PHASE3Recruiting
406 participants
Started: Sep 26, 2024 · Completed: Oct 19, 2026
1 condition1 sponsor254 locations
NCT06579027
A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia
NARecruiting
30 participants
Started: Sep 26, 2024 · Completed: Sep 1, 2026
3 conditions2 sponsors1 location
NCT06463665
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
PHASE2Recruiting
142 participants
Started: Sep 26, 2024 · Completed: Jul 31, 2029
8 conditions2 sponsors16 locations
NCT06693960
Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach
EARLY_PHASE1Recruiting
16 participants
Started: Sep 26, 2024 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT06504238
Non-Invasive Monitoring Methods in Patients With Acute Brain Injury
N/ARecruiting
720 participants
Started: Sep 26, 2024 · Completed: Sep 30, 2030
1 condition1 sponsor1 location